Adverse events including extrapyramidal effects · terminally ill adults with delirium
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events including extrapyramidal effects · terminally ill adults with delirium
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse effects (related to engagement with VR) · children (0 to 18 years)
1 finding from 1 review
Adverse effects (related to engagement with VR) · children (0‐18 years)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse effects (related to engagement with VR) · children (0 to 18 years)
1 finding from 1 review
Intervention not reported
Adverse effects ‐ any important adverse effects · people with antipsychotic‐induced tardive dyskinesia
1 finding from 1 review
Adverse effectsNo. of participants: 1754(9 RCTs) · patients with newly diagnosed multiple brain metastases
1 finding from 1 review
no estimate extracted
Studies not reported
High
Adverse effectsNo. of participants: 1754(9 RCTs) · patients with newly diagnosed multiple brain metastases
1 finding from 1 review
no estimate extracted
Studies not reported
High
Discomfort/pain · adults and children with ear wax requiring removal
Ear drops (any active treatment) may leads to lower adverse effects: discomfort, irritation or pain compared with no treatment (low certainty).
1 finding from 1 review
Discomfort/pain · adults and children with ear wax requiring removal
Ear drops (any active treatment) may leads to lower adverse effects: discomfort, irritation or pain compared with ear drops (water or saline) (low certainty).
1 finding from 1 review
Discomfort/pain · adults and children with ear wax requiring removal
Ear drops (water or saline) may leads to lower adverse effects: discomfort, irritation or pain compared with no treatment (low certainty).
1 finding from 1 review
Gastrointestinal adverse events · chronic rhinosinusitis
Systemic antifungal showed no clear difference in adverse effects ‐ gastrointestinal disturbances compared with placebo/no treatment (low certainty).
1 finding from 1 review
RR 0.37 [0.04, 3.36]
Studies not reported
Low
Adverse effects: Specific ‐ EPS during 24 hours · patients with psychosis‐induced aggression or agitation
HALOPERIDOL showed no clear difference in adverse effects: Specific ‐ EPS during 24 hours compared with OTHER ANTIPSYCHOTIC: h. RISPERIDONE (low certainty).
1 finding from 1 review
Adverse effect: Specific ‐ hypotensive episode · patients with psychosis‐induced aggression or agitation
1 finding from 1 review
Adverse events: psychological disorders · people who are aggressive secondary to serious mental illness
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse effects ‐ needing anticholinergic drugs · patients with schizophrenia
It is very uncertain whether bromperidol decanoate changes adverse effects ‐ needing anticholinergic drugs compared with other depot antipsychotic drugs (very low certainty).
1 finding from 1 review
Adverse effects: number needing cytotoxic agents · SSNS in children
It is very uncertain whether cyclosporin plus prednisolone changes adverse effects: number needing cytotoxic agents compared with prednisolone alone (very low certainty).
1 finding from 1 review
Psychiatric adverse effects (roflumilast 500 µg) · patients with stable chronic obstructive pulmonary disease
Phosphodiesterase‐4 inhibitors probably leads to higher psychiatric adverse effects (roflumilast 500 µg) compared with placebo (moderate certainty).
1 finding from 1 review
Adverse events including extrapyramidal effects · terminally ill adults with delirium
Summary of findings: risperidone showed no clear difference in adverse events including extrapyramidal effectsd compared with placebo (low certainty).
1 finding from 1 review
Adverse events including extrapyramidal effects · terminally ill adults with severe delirium
It is very uncertain whether summary of findings: lorazepam plus haloperidol changes adverse events including extrapyramidal effectsd compared with placebo plus haloperidol (very low certainty).
1 finding from 1 review